Newsroom
Sorted by: Latest
-
Island Named to CNBC Disruptor 50 List for Accelerating AI Adoption in the Enterprise Workplace
DALLAS--(BUSINESS WIRE)--Island, the platform for enterprise AI work, has been named to the CNBC Disruptor 50 list for 2026, earning the #28 spot. The annual list recognizes “the most promising venture-backed companies innovating across industries, experimenting with AI and, increasingly, making it work at scale.” Island is redefining how work gets done in the agentic AI era by uniting productivity, IT, and security across its Enterprise Browser, consumer browsers, and desktops. Island replaces...
-
Modon gaat een samenwerking aan met Montage Hotels & Resorts om het ultraluxe hospitalitymerk naar Ras El Hekma in Egypte te brengen
Ras El Hekma, Egypte--(BUSINESS WIRE)--Het in Abu Dhabi gevestigde Modon Holding en Montage Hotels & Resorts hebben Montage Ras El Hekma aangekondigd dat ze de eerste merkwoningen te koop gaan introduceren in Ras El Hekma aan de Middellandse Zeekust van Egypte. Dit is het eerste Montage-resort in Egypte, ter ondersteuning van de groei van de opkomende stad als een wereldwijde hub voor vrije tijd, zaken en toerisme. Montage Ras El Hekma krijgt 200 kamers en suites, naast 96 Montage Residence...
-
Kubota Vision Inc. signe un accord d'approvisionnement et de licence avec les Laboratoires KÔL pour un médicament candidat dans la maladie de Stargardt sous Accès Compassionnel
CLERMONT-FERRAND, France et TOKYO, Japon--(BUSINESS WIRE)--Kubota Vision Inc. (« Kubota Vision »), filiale détenue en exclusivité par Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japon), a annoncé la signature d’un accord de fourniture et de licence avec les Laboratoires KÔL (Clermont-Ferrand, France) pour la fourniture d’un médicament pour la maladie de Stargardt (STGD1) sous autorisation d’Accès Compassionnel. Le présent accord a pour objet que Kubota Vision et KÔL collaborent...
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Tyler Technologies to Deliver Easier Bookings for Park Visitors in Australia
PLANO, Texas--(BUSINESS WIRE)--Tyler Technologies announced an agreement with the Tasmania Parks and Wildlife Service in Australia for Tyler’s Recreation Management solution....
-
Riassunto: LogicMonitor e Deutsche Telekom ampliano la loro partnership in tutta Europa
LONDRA--(BUSINESS WIRE)--LogicMonitor ®, la piattaforma incentrata sull'AI per l'IT autonomo, oggi ha annunciato l'espansione della disponibilità della propria soluzione nell'ambito del portafoglio di servizi gestiti targati Deutsche Telekom in selezionati mercati europei, tra cui la regione DACH, il Benelux e i paesi del Nord Europa. Questa espansione si basa sull'utilizzo operativo di LogicMonitor nel Regno Unito a partire dal 2023, con il supporto dei team di assistenza di Deutsche Telekom p...
-
Barclays Research Expects Humanoid Robots to Fundamentally Reshape the Real Economy
LONDON--(BUSINESS WIRE)--In this year’s Equity Gilt Study, Barclays Research examines how physical AI will move beyond the digital realm and into the real economy, with humanoid robots set to reshape productivity, labour markets, geopolitics, and long-term asset returns. While equities delivered strong real returns in 2025, the report argues that the more important shift is structural, marked by higher capital investment, rising productivity, and a repricing of growth, inflation, and capital ac...
-
Sensome Announces Positive First-in-Human Study Results for In Situ Tumor Detection Technology for Lung Cancer
PARIS--(BUSINESS WIRE)--Sensome announces positive first-in-human results for its in situ tumor detection technology for lung cancer....
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Samenvatting: LogicMonitor en Deutsche Telekom breiden hun partnerschap in Europa uit
LONDEN--(BUSINESS WIRE)--LogicMonitor®, het AI-first platform voor Autonomous IT, maakte vandaag de uitgebreide beschikbaarheid bekend van zijn platform in de portfolio beheerde services van Deutsche Telekom in een selectie van Europese markten, waaronder DACH, Benelux en de Scandinavische landen. De uitbreiding is gestoeld op operationeel gebruik van LogicMonitor in het Verenigd Koninkrijk sinds 2023, waar het de serviceteams van Deutsche Telekom heeft ondersteund bij het verbeteren van zichtb...